Predictors of recurrence after pancreaticoduodenectomy in ampullary cancer: Comparison between non-, early and late recurrence

Journal of the Formosan Medical Association

Volumn 106, Issue 6, 2007, Pages 432-443

  Hsu, Hui Ping ^a,b   Shan, Yan Shen ^a   Hsieh, Yu Hsiang ^c   Yang, Ta Ming ^d   Lin, Pin Wen ^a  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d TAINAN MUNICIPAL HOSPITAL   (Taiwan)

Author keywords

Adenocarcinoma; Ampulla of Vater; Predictors of recurrence

Indexed keywords

EPIRUBICIN; FLUOROURACIL; FOLINIC ACID; GEMCITABINE; MITOMYCIN; OXALIPLATIN; TEGAFUR; URACIL;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER RECURRENCE; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE SEVERITY; EARLY CANCER; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LONG TERM CARE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; MULTIVARIATE ANALYSIS; PANCREATICODUODENECTOMY; PELVIS LYMPHADENECTOMY; POSTOPERATIVE CARE; PROGNOSIS; SURVIVAL RATE; TUMOR VOLUME; VATER PAPILLA CARCINOMA;

EID: 34447312711     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-6646(09)60292-8     Document Type: Article

References (27)

1. Yamaguchi K, Enjoji M. Carcinoma of the ampulla of Vater: a clinicopathologic study and pathologic staging of 109 cases of carcinoma and 5 cases of adenoma. Cancer 1987; 59:506-15.
2. Yeo CJ, Cameron JL. Sohn TA, et al. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s. Ann Surg 1997;226:248-60.
3. Nakase A, Matsumoto Y, Uchida K, et al. Surgical treatment of cancer of the pancreas and the periampullary region: cumulative results in 57 institutions in Japan. Ann Surg 1977;185:52-7.
4. Todoroki T, Koike N, Morishita Y, et al. Patterns and predictors of failure after curative resections of carcinoma of the ampulla of Vater. Ann Surg Oncol 2003;10:1176-83.
5. Talamini MA, Moesinger RC, Pitt HA, et al. Adenocarcinoma of the ampulla of Vater: a 28-year experience. Ann Surg 1997;225:590-600.
6. Roder JD, Schneider PM, Stein HJ, et al. Number of lymph node metastases is significantly associated with survival in patients with radically resected carcinoma of the ampulla of Vater. Br J Surg 1995;82:1693-6.
7. Böttger TC, Boddin J, Heintz A, et al. Clinicopathologic study for the assessment of resection for ampullary carcinoma. World J Surg 1997;21:379-83.
8. Kayahara M, Nagakawa T, Ohta T, et al. Surgical strategy for carcinoma of the papilla of Vater on the basis of lymphatic spread and mode of recurrence. Surgery 1997;121: 611-7.
9. Kim RD, Kundhal PS, McGilvray ID, et al. Predictors of failure after pancreaticoduodenectomy for ampullary carcinoma. J Am Coll Surg 2006;202:112-9.
10. Mehta VK, Fisher GA, Ford JM, et al. Adjuvant chemoradiotherapy for "unfavorable" carcinoma of the ampulla of Vater: preliminary report. Arch Surg 2001;136:65-9.
11. Lin PW, Lee JC, Lee PC, et al. A simple, secure and universal pancreaticojejunostomy following pancreaticoduodenectomy. HPB Surg 1997;10:305-10.
12. Lin PW, Lin YJ. Prospective randomized comparison between pylorus-preserving and standard pancreaticoduodenectomy. Br J Surg 1999;86:603-7.
13. Shan YS, Sy ED, Lin PW. Role of somatostatin in the prevention of pancreatic stump-related morbidity following elective pancreaticoduodenectomy in high-risk patients and elimination of surgeon-related factors: prospective, randomized, controlled trail. World J Surg 2003;27: 709-14.
14. Greene FL, Page DL, Fleming ID, et al. AJCC Cancer Staging Manual, 6th edition. New York: Springer, 2002: 151-3.
15. Hsu HP, Yang TM, Hsieh YH, et al. Predictors for patterns of failure after pancreaticoduodenectomy in ampullary cancer. Ann Surg Oncol 2007;14:50-60.
16. Schmidt CM, Powell ES, Yiannoutsos CT, et al. Pancreaticoduodenectomy: a 20-year experience in 516 patients. Arch Surg 2004;139:718-27.
17. Howe JR, Klimstra DS, Maccia RD, et al. Factors predictive of survival in ampullary carcinoma. Ann Surg 1998;228: 87-94.
18. Yoon YS, Kim SW, Park SJ, et al. Clinicopathologic analysis of early ampullary cancers with a focus on the feasibility of ampullectomy. Ann Surg 2005;242:92-100.
19. Beger HG, Treitschke F, Gansauge F, et al. Tumor of the ampulla of Vater: experience with local or radical resection in 171 consecutively treated patients. Arch Surg 1999; 134:526-32.
20. Brown KM, Tompkins AJ, Yong S, et al. Pancreaticoduodenectomy is curative in the majority of patients with node-negative ampullary cancer. Arch Surg 2005;140:529-33.
21. Monson JR, Donahue JH, McEntee GP, et al. Radical resection for carcinoma of the ampulla of Vater. Arch Surg 1991; 126:353-7.
22. Balachandran P, Sikora SS, Kapoor S, et al. Long-term survival and recurrence patterns in ampullary cancer. Pancreas 2006;32:390-5.
23. Klempnauer J, Ridder GJ, Maschek H, et al. Carcinoma of the ampulla of Vater: determinants of long-term survival in 94 resected patients. HPB Surg 1998;11:1-11.
24. Sakata E, Shirai Y, Yokoyama N, et al. Clinical significance of lymph node micrometastasis in ampullary carcinoma. World J Surg 2006;30:985-91.
25. Mizuno T, Ishizaki Y, Ogura K, et al. Clinical significance of immunohistochemically detectable lymph node metastasis in adenocarcinoma of the ampulla of Vater. Br J Surg 2006;93:221-5.
26. Shirai Y, Tsukada K, Ohtani T, et al. Carcinoma of the ampulla of Vater: histopathologic analysis of tumor spread in Whipple pancreaticoduodenectomy specimens. World J Surg 1995;19:102-7.
27. Sikora SS, Balachandran P, Dimri K, et al. Adjuvant chemoradiotherapy in ampullary cancers. EJSO 2005;31:158-63.